Matthew J. Leonard's most recent trade in ANI Pharmaceuticals Inc was a trade of 2,528 Common Stock done at an average price of $90.6 . Disclosure was reported to the exchange on Aug. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Matthew J. Leonard | Director | Sale of securities on an exchange or to another person at price $ 90.62 per share. | 25 Aug 2025 | 2,528 | 6,864 (0%) | 0% | 90.6 | 229,087 | Common Stock |
| ANI Pharmaceuticals Inc | Matthew J. Leonard | Director | Sale of securities on an exchange or to another person at price $ 88.17 per share. | 18 Aug 2025 | 6,937 | 9,392 (0%) | 0% | 88.2 | 611,635 | Common Stock |
| ANI Pharmaceuticals Inc | Matthew J. Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 4,336 | 16,329 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Matthew J. Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 4,410 | 11,993 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Matthew J. Leonard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 7,583 | 7,583 (0%) | 0% | 0 | Common Stock |